Endocrine News Podcast
The Endocrine News Podcast, a free service of the Endocrine Society, features interviews with experts addressing the latest research and trends in the field of endocrinology. Listeners can suggest topics for future episodes by emailing podcast@endocrine.org.
Episodes
Bisphenols and the Thyroid
This episode looks at bisphenols and the thyroid, asking questions such as: What is BPA? Where is it found? And what do we know about the possible health risks regarding exposure to it? Host Aaron Lohr talks with Kailey Caroland, a cancer biology PhD candidate at Vanderbilt University School of Medicine, about her ENDO 2026 abstract on the topic titled, "Bisphenol A, and Alternative Bisphenols S,
Impact of Androgen Receptors on Estrogen Receptor-Positive Breast Cancer Microenvironments
Estrogen receptor positive breast cancer (ER+ BC) is the most frequently diagnosed subtype of BC with consequent highest mortality. For patients with ER+ BC, standard of care treatments are endocrine therapies targeting ER expression and activity or aromatase inhibitors that block synthesis of estrogens from adrenal androgens. However, it is estimated that nearly 33% of all patients with ER+ BC wi
ENP113: Clinical Practice Guideline on Central Precocious Puberty
The Endocrine Society recently released a new Clinical Practice Guideline (CPG) on Central Precocious Puberty. Among its many recommendations, the CPG says some subgroups of children with precocious puberty—such as older girls with slowly progressing puberty—may not need the same level of testing or treatment.Central precocious puberty happens when a child’s brain activates puberty-related hormone
ENP112: Osteoporosis and the SABRE Project
The U.S. Food and Drug Administration recently qualified "total hip bone mineral density" as a surrogate endpoint to support clinical trials for osteoporosis drugs. This decision will significantly impact clinical trials moving forward, as the traditional endpoint of "fracture outcomes" presented many challenges regarding sample size, duration, and cost. The change came about because of findings f
ENP111: Addressing the Endocrine Workforce Shortage
The endocrine workforce shortage is affecting the lives of endocrinologists and the patients they treat. Many practices would benefit from any support that would give endocrinologists more capacity to focus where they really need to. Could advance practice providers, such as nurse practitioners and physicians assistants, be able to provide that support if they had a little more training? The End
ENP110: Hypercortisolism and T2D
ENP109: Anti-Obesity Medications (CME credit available)
ENP108: AI and Robotics in Surgery
ENP107: Compounded Obesity Medications
ENP106: Reversing Bariatric Surgery
ENP105: Tirzepatide and Menopause
ENP104: Hidden Ingredients in Supplements
ENP103: Type 1 Diabetes: Immunotherapies and Early Detection
ENP102: Insulin Delivery Systems (CME credit available)
ENP101: Papillary Thyroid Cancer
ENP100: Growth Hormone Deficiency
ENP99: Fracture Liaison Services
ENP98: Opioids and the Endocrine System
ENP97: Childhood Obesity Treatment
ENP96: Automated Insulin Delivery Systems
There is a lot of interest in automated insulin delivery systems, and they were covered in depth at the Endocrine Society’s Type 1 Diabetes Fellows Series, held earlier this year. Joining host Aaron Lohr to talk about these delivery systems is Grazia Aleppo, MD, a professor of medicine at Northwestern University and a presenter at the T1D Fellows Series. Show notes are available at https://www.end
ENP95: Environmental Impact on Early Female Puberty
There are plenty of studies showing that chemicals found in the environment can directly impact human health. Some new research finds that certain environmental compounds may trigger early female puberty. Joining host Aaron Lohr to talk about that research is Natalie Shaw, MD, a Lasker clinical research scholar and principal investigator of the pediatric neuroendocrinology group in the Clinical Re
ENP94: Update on Acromegaly
It’s been a few years, but we are here with an update on acromegaly, covering prevalence, diagnosis, traditional treatment, new therapies, and current gaps in understanding. Host Aaron Lohr talks again with Maria Fleseriu, MD, professor of medicine and professor of neurological surgery at Oregon Health & Science University School of Medicine and director of OHSU’s Pituitary Center. Dr. Fleseriu al
ENP93: Prioritizing Patient Experience in Managing Diabetes
Host Aaron Lohr talks with Rita Kalyani, MD, professor of medicine at Johns Hopkins University School of Medicine and president-elect of medicine and science at the American Diabetes Association. Earlier this year, Dr. Kalyani and colleagues published a position statement in The Journal of Clinical Endocrinology & Metabolism titled, “Prioritizing Patient Experiences in the Management of Diabetes a
ENP92: Pheochromocytomas
In this episode, we talk about pheochromocytomas. Host Aaron Lohr talks with Nikhitha Chandrashekar, MD, who recently finished her endocrinology fellowship at University Hospitals Case Western Reserve University in Cleveland. Dr. Chandrashekar presented a case study on pheochromocytomas at ENDO 2024. Show notes are available at https://www.endocrine.org/podcast/enp92-pheochromocytomas — for helpfu
ENP91: Hypothyroidism and Muscle Regeneration
Our bodies typically do a remarkable job of recovering from certain injuries, and thyroid hormone signaling has an essential role to play there. But what is that process like for someone with hypothyroidism, and is there a unique role in that process for muscle stem cells? Host Aaron Lohr talks with Paola Aguiari, PhD, a senior research specialist at Children’s Hospital Los Angeles. She presented
ENP90: Early Life Stress and Substance Use
We all know that stress leads to a number of negative outcomes. In this episode, we talk about how early life stress may influence youth substance use initiation and some endocrine factors that may be helping to drive that influence. Host Aaron Lohr talks with Alexandra M. Donovan, PhD, of the Charles R. Drew University of Medicine and Science. Dr. Donovan recently presented an abstract at ENDO 20
ENP89: Brown Fat and Metabolic Function
In this episode, we talk about brown fat and some new discoveries in how it regulates metabolic function. Joining host Aaron Lohr is Marsel Lino, PhD, a research fellow at Joslin Diabetes Center in Boston. Dr. Lino presented an abstract at ENDO 2024 titled, “A New Layer of Endocrine Regulation: Brown Fat Secretes Exosomal MicroRNAs, Which Regulate Metabolic Functions and Distal Organs.” Show notes
ENP88: Glucocorticoids in Supplements
Many people take over-the-counter supplements for a variety of reasons, but it isn’t always clear what’s in those supplements. And while they may be intended to help, some may cause harm. In this episode, host Aaron Lohr talks with Kevin Wei, MD, from the University of Southern California/Los Angeles General Medical Center Internal Medicine Residency Program about the presence of glucocorticoids i
ENP87: Short-Term Weight Loss in Adolescents With Obesity
For those of us who try to lose weight at some point in time, we know the frustration of losing weight and feeling good about that, only to see that weight return. Why does that happen? Is the process the same for adults and adolescents? Is there any way to mitigate that weight regain? Joining host Aaron Lohr is Eric Bomberg, MD, assistant professor at the Center for Pediatric Obesity Medicine at
ENP86: Machine Learning and Steatotic Liver Disease
ENP85: Treat and Reduce Obesity Act
In this episode, we focus on the Treat and Reduce Obesity Act legislation and the obesity epidemic. Host Aaron Lohr talks with U.S. Rep. Raul Ruiz, MD, a physician and currently the U.S. Representative for California’s 25th congressional district. Rep. Ruiz received his medical degree from Harvard University and completed his residency in emergency medicine at the University of Pittsburgh and a fe
ENP84: Fibrodysplasia Ossificans Progressiva
In a special episode, we discuss a complex, rare disease, fibrodysplasia ossificans progressiva, or FOP. Host Aaron Lohr talks with three guests: Eileen M. Shore, PhD, Cali and Weldon Research Professor in FOP and co-director of the Center for Research in FOP and Related Disorders at the University of Pennsylvania School of Medicine; Elisabeth Marelise W. Eekhoff, MD, PhD, endocrinologist, princi
ENP83: Sedentary Time and Physical Activity Effects on Childhood Lipid Levels
We all know that a sedentary lifestyle is not healthy for anyone, but just how strongly is physical activity connected to lipid levels in childhood? Host Aaron Lohr talks with Andrew Agbaje, MD, PhD, a physician and pediatric clinical epidemiologist at the University of Eastern Finland. He has authored a study recently published in The Journal of Clinical Endocrinology & Metabolism titled, “Associ
ENP82: PFAS
In this episode, we learn about endocrine-disrupting chemicals known as perfluoroalkyl and polyfluoroalkyl substances (PFAS), which break down so slowly that they have been called “forever chemicals.” Where can PFAS be found? What exactly is their effect on human health? What are manufacturers doing to limit exposure, and is it enough? Host Aaron Lohr talks with Benson T. Akingbemi, PhD, professor
ENP81: Obesity Fellows Program
According to the National Institutes of Health, more than two in five adults have obesity in the United States, and nearly one in three is overweight. To equip health care practitioners with the resources they need to treat patients with obesity, the Endocrine Society recently held its innaugual obesity fellows program, an exclusive, application-based, educational activity for current fellows. The
ENP80: Metabolic and Neuroendocrine Effects of Short Sleep
We all know that sleep is important, but sometimes we just don’t get enough. We also know the normal side effects from lack of sleep, but are there other, metabolic, and neuronendocrine effects from short sleep that we don’t know about. Host Aaron Lohr talks about this with Iris CM Pelsma, an academic researcher at Leiden University Medical Center in the Netherlands. She and her colleagues present
ENP79: Type 1 Diabetes Update
Today’s topic is type 1 diabetes. What are some of the biggest challenges facing us today when it comes to diagnosing and treating type 1 diabetes, and how can we meet those challenges? Host Aaron Lohr talks with Irl Hirsch, MD, from the UW Diabetes Institute at the University of Washington. Dr. Hirsch and Davida Kruger, NP, from Henry Ford Health in Detroit co-chaired the Endocrine Society’s type
ENP78: Post-Cycle Therapy Following Anabolic-Androgenic Steroid Cessation
We know that illicit use of anabolic-androgenic steroids is dangerous, but cessation comes with its own challenges. Today we’re talking about a study presented at ENDO 2023 titled, “Self-Administration of Post-Cycle Therapy Is Associated With Increased Probability of Subsequent Normalisation of Reproductive Hormones Following Anabolic-Androgenic Steroid Cessation in Men.” Joining host Aaron Lohr t
ENP77: Phthalates and Endocrine Puberty
We look at a study, presented at ENDO 2023, about the endocrine-disrupting chemicals known as phthalates, or plasticizers, and their effects on fetal and neonatal endocrine puberty. Host Aaron Lohr talks with Mary Bunnell from the University of Illinois Urbana-Champaign, co-author of the study, titled, “Prenatal Phthalate Exposure Alters the Pattern of Fetal and Neonatal Endocrine Puberty in a Sex
ENP76: Infants and In Utero Exposure to COVID
ENP75: A Case Study on Fungal Sinusitis in T2D
From ENDO 2023, host Aaron Lohr talks with Jayalakshmi Udayasankar, MD, from the Palo Alto Medical Foundation, about her team’s research presented at the meeting, titled, “Tingling Over Cheek: An Atypical Presentation of Invasive Fungal Sinusitis in an Ambulatory Patient With Type 2 Diabetes.” Show notes are available at https://www.endocrine.org/podcast/enp75-a-case-study-on-fungal-sinusitis-in-t
ENP74: Healthy and Unhealthy Obesity
In another dispatch from ENDO 2023, host Aaron Lohr talks with Max Petersen, MD, PhD, from Washington University in St. Louis, about his team’s research presented at the meeting. Their presentation was titled, “Cellular Insights Into Metabolically Healthy and Unhealthy Obesity.” Show notes are available at https://www.endocrine.org/podcast/enp74-healthy-and-unhealthy-obesity — for helpful links or
ENP73: A Robotic Teriparatide Pill to Treat Osteoporosis
Host Aaron Lohr talks with two researchers at ENDO 2023, Kyle Horlen, DVM, and Joshua Myers, both from Rani Therapeutics, about two presentations they made about an oral treatment of teriparatide for the treatment of osteoporosis. The two presentations are titled, “Pharmacokinetics (PK) and Pharmacodynamics (PD) of the Parathyroid Hormone Analog PTH (1-34) (Teriparatide) Delivered via an Orally Ad
ENP72: GHR, Insulin, and Life Span
In another interview from ENDO 2023, host Aaron Lohr talks with Silvana Duran Ortiz, Ph.D., a postdoctoral research fellow at Ohio University, about her team’s research presented at the meeting. Their presentation was titled, “Disruption of GHR in ‘Middle Aged’ Mice Enhances Insulin Sensitivity and Extends Male Lifespan.” Show notes are available at https://www.endocrine.org/podcast/enp72-ghr-insu
ENP71: Lactation and Maternal Metabolism
ENP70: Hormones and Aging
Whether we like it or not, we’re all getting older. What do we know about how aging impacts our endocrine system? What don’t we know? That’s what we’re here to talk about today, as we look at the new scientific statement from the Endocrine Society titled, “Hormones and Aging: An Endocrine Society Scientific Statement.” Host Aaron Lohr talks with one of the statement’s authors, Anne Cappola, MD, a
ENP69: Biosimilar Insulin
In this episode, we hear about biosimilar insulin: its safety, efficacy, what sets it apart from biologic insulin, and when it should be considered for use. Host Aaron Lohr talks with Irl Hirsch, MD, professor of medicine at the University of Washington Medicine Diabetes Institute. This episode is made possible through an unrestricted, educational grant from Viatris. Show notes are available at ht
ENP68: Hypercalcemia of Malignancy
Recently the Endocrine Society published a new clinical practice guideline entitled, “Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline.” What exactly is hypercalcemia of malignancy? What are its symptoms? How is it treated? And what do the guidelines recommend? To help answer these questions, host Aaron Lohr talks with Ghada El-Hajj Fuleihan, MD,
ENP67: Growth Hormone Deficiency
In this episode, host Aaron Lohr discusses screening, diagnosis, and current and emerging treatment options for the long-term management of growth hormone deficiency in pediatric and adult patients with Dr. Mark E. Molitch, MD, Professor Emeritus of Medicine, Northwestern University Feinberg School of Medicine. In addition, Dr. Molitch gives listeners a four-question quiz at the end. Remember to p
ENP66: New Endocrine Society Journal JCEM Case Reports
ENP65: Type 1 Diabetes and Challenges Across the Lifespan
In this episode, host Aaron Lohr looks back at the Endocrine Society’s Type 1 Diabetes Fellows Conference, which occurred last year, with two conference presenters talking about developmental challenges in type 1 diabetes, including psychological and social, across the lifespan. Our guests are Linda Siminerio, PhD, professor of medicine at University of Pittsburgh and executive director of the uni
ENP64: More Testing Needed for Men With Hypogonadism
In this episode, Aaron talks with Travis Goettemoeller, MD, internal medicine resident at Cleveland Clinic, about an abstract he and a colleague presented at ENDO 2022 about the bone mineral density testing of men for hypogonadism. The abstract is titled, “Lack of Bone Mineral Density Testing in Men with Hypogonadism: A Clinical Conundrum.” Show notes are available at https://www.endocrine.org/pod
ENP63: Vosoritide and Children With Genetic Short Stature
We look at Vosoritide, a promising, potential treatment for children with genetic short stature who do not have chondrodysplasia. Host Aaron Lohr talks with Andrew Dauber, MD, division chief of endocrinology at Children’s National Hospital. Dr. Dauber and colleagues presented about Vosoritide at ENDO 2022. Their abstract is titled, “A Prospective Clinical Trial of Vosoritide in Selected Genetic Ca
ENP62: Parabens as an EDC and Addressing Disparities in Risk and Research
Endocrine-disrupting chemicals are pretty much everywhere, and all of us have some level of exposure. Today we will talk about research presented at ENDO 2022 on a group of EDCs called parabens. The title of that abstract is “Parabens Promote Pro-Tumorigenic Effects in Luminal Breast Cancer Cell Lines With Diverse Genetic Ancestry.” Host Aaron Lohr talks with one of the authors of that study, Lind
ENP61: Islet Cell Transplantation for Diabetes
In this episode, we talk about an exciting experimental treatment for patients with type 1 diabetes called islet cell transplantation. Host Aaron Lohr talks with David Baidal, MD, assistant professor of medicine at the University of Miami Miller School of Medicine. This episode is made possible through an unrestricted, educational grant from Vertex Pharmaceuticals. Show notes are available at http
ENP60: CGM and Prediabetes
We know how helpful continuous glucose monitors are for individuals with diabetes, but might they be of benefit to individuals with prediabetes? Today host Aaron Lohr will talk with Hisham Farhan, MD, an endocrinology fellow at the University of Maryland Medical Center. Dr. Farhan and colleagues made an oral presentation at ENDO 2022 titled, “Impact of Continuous Glucose Monitoring (CGM) on Lifest
ENP59: Fructose and Liver Disease
Fructose is sweeter than glucose and is often added to processed foods as a sweetener, commonly in the form of high-fructose corn syrup. Some studies suggest that fructose consumption may be associated with nonalcoholic fatty liver disease, and some new research, recently presented at ENDO, addresses this issue. Host Aaron Lohr talks with one of the authors of this research, Theodore Friedman, MD,
ENP58: Oncoendocrinology
Today we shine a spotlight on a fascinating area of focus within endocrinology that maybe you haven't heard much about: oncoendocrinology. What is it, and how are health providers working together to care for patients who have endocrine conditions and cancer? Host Aaron Lohr talks with Afreen I. Shariff, MD, an endocrinologist at Duke University School of Medicine with expertise in endocrine disea
ENP57: Male Runners and Bone Health
We know that exercise is good for us, but for athletes who run, how might that level of running impact their bones? Host Aaron Lohr talks about new research on this topic presented at ENDO 2022 with one of the study’s presenters, Melanie Schorr Haines, MD, assistant professor of medicine at Massachusetts General Hospital. Dr. Haines and colleagues’ presentation at ENDO 2022 is titled, “Male Runner
ENP56: Gestational Diabetes, Maternity Blues, and T2D
In this episode, Aaron talks with Jennifer Dias from the Icahn School of Medicine at Mount Sinai about gestational diabetes, its association with postpartum depressive symptoms (“maternity blues”), and a predictor that may help prevent gestational diabetes from developing into type 2 diabetes. Ms. Dias, an MD candidate, presented research at ENDO 2022 titled, “Predictors of Postpartum Depressive S
ENP55: Serum IgA and Type 1 Diabetes in Children
In this episode, we talk about a potential marker to help identify youth with type 1 diabetes, islet autoimmunity, and insulin deficiency. This new research was presented at ENDO 2022, and the abstract is titled, “Elevated Serum IgA at Onset of Type 1 Diabetes in Children.” Host Aaron Lohr speaks with one of the authors, Amruta Thakkar, MD, of Texas Children’s Hospital and the Baylor College of Me
ENP54: Obesity Pharmacotherapy
We all know how important diet and exercise are to weight loss and maintenance, but what about anti-obesity medications? How efficient are they? Host Aaron Lohr speaks with Michael Weintraub, MD, clinical fellow in endocrinology, diabetes, and metabolism at New York-Presbyterian Hospital/Weill Cornell Medical Center. Dr. Weintraub and colleagues presented in an oral session during the Endocrine So
ENP53: Ovulatory Disturbances and SARS-COV2
Host Aaron Lohr returns to in-person interviews, starting with the Endocrine Society's 2022 annual meeting in Atlanta. Here he talks about the effects of SARS-COV2 on ovulation with someone we have been talking with since the beginning: Jerilynn C. Prior, MD, professor of endocrinology and metabolism at the University of British Columbia in Vancouver. Dr. Prior and colleagues presented in an oral
ENP52: Incretins and Type 2 Diabetes Management
Host Aaron Lohr talks about incretins and type 2 diabetes management with Zhenqi Liu, MD, chief of the Division of Endocrinology and Metabolism at the University of Virginia School of Medicine. This episode is certified for up to 0.5 American Medical Association Physician's Recognition Award (AMA PRA) Category 1 credits and American Board of Internal Medicine Maintenance of Certification (ABIM MOC
ENP51: Re-evaluating Standards for Bisphenol A
In recent years, much attention has been paid to the amount of Bisphenol A, or BPA, an endocrine-disrupting chemical, found in plastic products. But are the standards we have in place enough? Host Aaron Lohr talks with Heather Patisaul, PhD, of North Carolina State University. An Endocrine Society member, Dr. Patisaul is an expert on BPA whose research contributed to findings from a coalition that
ENP50: Drones, Robots, and Diabetes Tech
For our 50th episode since launching in 2018, host Aaron Lohr takes a look at drone and robotic technology being used for medicine delivery and patient education. He speaks with Derek O’Keeffe, MD, PhD, of the National University of Ireland, Galway, who has been at the forefront of this development in patient care. Dr. O’Keeffe will present on Tuesday, November 9, at the Endocrine Society's upcomi
ENP49: Cardiovascular Disease and Type 2 Diabetes
Host Aaron Lohr talks about cardiovascular disease and type 2 diabetes with Jonathan Purnell, MD, from Oregon Health & Science University. Dr. Purnell chaired the Endocrine Society's recent educational series, “Current and Future State of Cardiovascular Disease in Type 2 Diabetes,” which is available through December 2021. For more information, including helpful links and other episodes, visit our
ENP48: Type 1 Diabetes
We explore type 1 diabetes, everything from diagnosis to treatment strategies, hypoglycemia, technology, and teleheath. Host Aaron Lohr talks with Irl Hirsch, MD, from the University of Washington, and Davida Kruger, NP, from the Henry Ford Health System. They co-chair the Endocrine Society's 8th Annual Endocrine Fellows Type 1 Diabetes Care and Management Program. For more information, including
ENP46: Vitamin D and COVID
Host Aaron Lohr talks about vitamin D insufficiency and COVID-19 with Laurel Mohrmann, MD, and Sweta Chekuri, MD, both from Montefiore Medical Center in the Bronx. Drs. Mohrmann and Chekuri participated on a team that presented in March on vitamin D insufficiency at ENDO 2021. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast
ENP45: Atypical Thyroiditis Induced by COVID-19
Host Aaron Lohr talks about thyroiditis and COVID-19 with Ilaria Muller, MD, PhD, from the University of Milan. Dr. Muller presented her research in March at ENDO 2021: “Early Follow-up of Atypical Thyroiditis Induced by SARS-CoV-2.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast
ENP44: Sodium Levels and COVID-19
A new study in The Journal of Clinical Endocrinology & Metabolism shows the relationship between abnormal sodium levels and greater risk of respiratory failure and death in patients with COVID-19. Host Aaron Lohr speaks with two of the authors, Ploutarchos Tzoulis, MD, PhD, from University College London Medical School and Julian Waung, PhD, from the Whittington Health NHS Trust in London. For mor
ENP43: What to Expect From ENDO 2021
The pandemic has changed the world of medical and science conferences, including the Endocrine Society's annual meeting, ENDO 2021, which will be an all-virtual event. Host Aaron Lohr talks with Felix Beuschlein, a professor at University Hospital Zurich and chair of the Society's annual meeting steering committee, about what to expect. ENDO 2021 will be held on March 20-23. For more information,
ENP42: 100 Years of Insulin
Today we celebrate 100 years since the discovery of insulin. We talk with Elizabeth A. Stephens, MD, an endocrinologist with the Providence Medical Group in Portland, Ore., about the importance of this landmark discovery, how it shaped our understanding and treatment of diabetes, and how it sets the stage for the exciting breakthroughs of tomorrow. For more information, including helpful links and
ENP41: Appetite Hormone Responses to Sugars
We look at sugars and appetite with Kathleen Page, MD, associate professor of medicine at the University of Southern California Keck School of Medicine. Dr. Page is the corresponding author of a new article published in The Journal of Clinical Endocrinology and Metabolism, “Appetite-Regulating Hormones Are Reduced After Oral Sucrose vs Glucose: Influence of Obesity, Insulin Resistance, and Sex.” F
ENP40: Time in Range
Host Aaron Lohr talks about time in range, hypoglycemia, and continuous glucose monitoring with Steven Edelman, MD, and Jeremy Pettus, MD, from the University of California, San Diego, and Rayhan Lal, MD, of Stanford University. Once you finish listening, take a survey, and you will receive a fashionable pancreas pin. The survey and all other links can be found at https://www.endocrine.org/podcast
ENP39: What's New in Obesity Treatment
Hear host Aaron Lohr's talk with Donna Ryan from Pennington Biomedical about the latest developments in obesity treatment. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.
ENP38: Hypoglycemia
Host Aaron Lohr talks about hypoglycemia with Elizabeth Seaquist, MD, from the University of Minnesota, and Cecilia Low Wang, MD, from the University of Colorado Hospital. Drs. Seaquist and Low Wang are the faculty of the ENDO Online 2020 session titled “Severe Hypoglycemia: The Frequently Forgotten Threat.” Once you have listened to the episode, let us know what you think about it by taking a sur
ENP37: Endocrine in the Time of COVID, Part 4
We continue in our four-part micro-series on endocrine in the time of COVID. Aaron talks more with Joshua Joseph, MD, assistant professor of medicine in the Division of Endocrinology, Diabetes, and Metabolism at The Ohio State University Wexner Medical Center. Dr. Joseph talks about disparities in research funding and the need for mentoring for young researchers, changes in policymaking that helps
ENP36: Endocrine in the Time of COVID, Part 3
We continue in our four-part micro-series on endocrine in the time of COVID. Here Aaron talks about the health disparities we see in the pandemic, especially those affecting African-American patients, with Joshua Joseph, MD, assistant professor of medicine in the Division of Endocrinology, Diabetes, and Metabolism at The Ohio State University Wexner Medical Center. For more information, including
ENP35: Endocrine in the Time of COVID, Part 2
We continue in our four-part micro-series on endocrine in the time of COVID. Aaron talks some more with Kathleen Dungan, MD, associate professor of medicine at the Ohio State University Division of Endocrinology, Diabetes, and Metabolism, about continuous glucose monitoring, training for caregivers and nurses, and telehealth. For more information, including helpful links and other episodes, visit
Recommended
پلی لیست | PlayList
English with Olivia | Slow Conversations & Vocabulary
Bible Tea
TED Talks Daily
Pod Save America
Dateline NBC
صداستان: ساعتی با موسیقی
Becoming: HER with Nikki Spoelstra
Exposing Workplace Bullying
Everyday AI Made Simple - AI For Everyday Tasks
FemTech Focus
Not Too Sensitive - Empowering Highly Sensitive People (HSPs) To Own Their Sensitivity
